Pradžia › Ūmi mieloidinė leukemija › Ohio › Cincinnati
Ūmi mieloidinė leukemija klinikiniai tyrimai Cincinnati, OH
20 tyrimai dėl Ūmi mieloidinė leukemija ieško dalyvių vietose Cincinnati ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- ir dar 3
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Renkami dalyviaiStebimasis tyrimas
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Renkami dalyviai3 fazė
- Oncology Hematology Care, Cincinnati
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Renkami dalyviai1 fazė
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Renkami dalyviai3 fazė
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Renkami dalyviaiStebimasis tyrimas
- University of Cincinnati, Cincinnati
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Renkami dalyviai3 fazė
- US-Cincinnati OH-CINCY, Cincinnati
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Renkami dalyviai3 fazė
- US-Cincinnati OH-CINCY, Cincinnati
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
Renkami dalyviai1 fazė
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · už 15 mylių
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Renkami dalyviai1/2 fazė
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Renkami dalyviai1 fazė
- Cincinnati Children's Hospital Medical Center, Cincinnati
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Renkami dalyviai3 fazė
- University of Cincinnati Medical Center (University Hospital), Cincinnati
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Renkami dalyviaiStebimasis tyrimas
- Cincinnati Children's Hospital, Cincinnati
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Renkami dalyviai1 fazė
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati, Cincinnati
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Renkami dalyviai1 fazė
- Cincinnati Children's Hospital, Cincinnati
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)
Renkami dalyviai1/2 fazė
- Cincinnati Children's Hospital Medical Center, Cincinnati
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
Renkami dalyviai1 fazė
- Cincinnati Children's Hospital Medical Center, Cincinnati
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
Renkami dalyviai2 fazė
- Cincinnati Children's Hospital Medical Center, Cincinnati
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
Renkami dalyviai1 fazė
- Oncology Hematology Care, Cincinnati
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Renkami dalyviai1 fazė
- University of Cincinnati, Cincinnati
Ūmi mieloidinė leukemija tyrimai kituose miestuose
- Houston, TX85 tyrimai
- New York City, NY51 tyrimas
- Boston, MA44 tyrimai
- Baldwin Park, CA40 tyrimai
- Seattle, WA40 tyrimai
- Columbus, OH35 tyrimai
- Philadelphia, PA34 tyrimai
- Durham, NC33 tyrimai
- Atlanta, GA30 tyrimai
- Tampa, FL29 tyrimai
- Chicago, IL26 tyrimai
- Portland, OR25 tyrimai
Kiti tyrimai Cincinnati
- Nedidelinių ląstelių plaučių vėžys35 tyrimai
- Vėžys (visų tipų)27 tyrimai
- Krūties vėžys25 tyrimai
- Širdies nepakankamumas24 tyrimai
- Storosios ir tiesiosios žarnos vėžys21 tyrimas
- Metastatinis vėžys20 tyrimai
- Kiaušidžių vėžys19 tyrimai
- Plaučių vėžys19 tyrimai
- Nutukimas19 tyrimai
- Prostatos vėžys18 tyrimai
- Kartotinė mieloma17 tyrimai
- Melanoma17 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.